Isoquinolinamine FX-9 Exhibits Anti-Mitotic Activity in Human and Canine Prostate Carcinoma Cell Lines

Current therapies are insufficient for metastatic prostate cancer (PCa) in men and dogs. As human castrate-resistant PCa shares several characteristics with the canine disease, comparative evaluation of novel therapeutic agents is of considerable value for both species. Novel isoquinolinamine FX-9 e...

Descripción completa

Detalles Bibliográficos
Autores principales: Schille, Jan Torben, Nolte, Ingo, Packeiser, Eva-Maria, Wiesner, Laura, Hein, Jens Ingo, Weiner, Franziska, Wu, Xiao-Feng, Beller, Matthias, Junghanss, Christian, Murua Escobar, Hugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888667/
https://www.ncbi.nlm.nih.gov/pubmed/31703454
http://dx.doi.org/10.3390/ijms20225567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888667/
https://www.ncbi.nlm.nih.gov/pubmed/31703454
http://dx.doi.org/10.3390/ijms20225567

Ejemplares similares